Company Filing History:
2 out of 34 
2 out of 67 
1 out of 832,891 Years Active: 2002-2006
Title: The Innovations of Gerard M Cagney
Introduction
Gerard M Cagney is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptides that enhance the transport of active agents through the gastrointestinal tract. With a total of 4 patents, Cagney's work has the potential to revolutionize drug delivery systems.
Latest Patents
Cagney's latest patents focus on random peptides that bind to gastrointestinal tract (GIT) transport receptors. These inventions relate to proteins, specifically peptides, that facilitate the transport of active agents through human or animal gastrointestinal tissue. The proteins and their derivatives are designed to enhance the absorption of drugs by targeting specific receptor sites or transport pathways in the GIT. This innovative approach allows for improved delivery of orally administered drugs into the systemic blood system.
Career Highlights
Throughout his career, Cagney has worked with prominent companies in the biotechnology sector. Notable among these are Cytogen Corporation and Elan Corporation, Plc. His experience in these organizations has contributed to his expertise in the field and has enabled him to develop groundbreaking inventions.
Collaborations
Cagney has collaborated with several professionals in his field, including Daniel Joseph O'Mahony and Vernon L Alvarez. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in drug delivery.
Conclusion
Gerard M Cagney's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work on peptides for drug transport has the potential to enhance therapeutic outcomes and improve patient care.